Ekadharma International Tbk. vs Merck Tbk. — how do they compare? Ekadharma International Tbk. trades at Rp169 (market cap 593.96B, 300 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 20.9K 24h volume). The key difference: Merck Tbk. is far larger — about 2.9× Ekadharma International Tbk.'s market cap, and Merck Tbk. is more actively traded (20.9K versus 300). Which is the better fit depends on your goals.
| EKAD | MERK | |
|---|---|---|
Market Cap | 593.96B | 1.7T |
Volume | 300 | 20.9K |
Lot | 3 | 209 |
Turnover | 50.9K | 80.13M |
Average Price | 169.67 | 3,833.92 |
Value | 50.9K | 80.13M |
Indicative Equilibrium Price | 170 | 3,850 |
Indicative Equilibrium Volume | 200 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ekadharma International Tbk (the Company) was established under the name of PT Ekadharma Widya Graphika based on Notarial Deed No. 71 dated November 20, 1981. PT Ekadharma Tape Industries Tbk manufactures computer continuous form paper and other related products. It also holds a manufacturing and distribution license from Nashua Corporation, USA.In August 2, 2006, The company's name was changed to PT Ekadharma International Tbk.
Read more on EKAD →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →